Cas:15015-57-3 4,4′-Disulfanediyldiphenol manufacturer & supplier

We serve Chemical Name:4,4′-Disulfanediyldiphenol CAS:15015-57-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4'-Disulfanediyldiphenol

Chemical Name:4,4′-Disulfanediyldiphenol
CAS.NO:15015-57-3
Synonyms:4,4′-Dithiodiphenol;4,4′-Disulfanediyldiphenol;Phenol, 4,4′-dithiobis-;MFCD00020164;4,4′-Dihydroxydiphenyl Disulfide;QR DSSR DQ;4-[(4-hydroxyphenyl)disulfanyl]phenol
Molecular Formula:C12H10O2S2
Molecular Weight:250.337
HS Code:2930909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:437.9±30.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.752
PSA:91.06000
Exact Mass:250.012222
LogP:2.74

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4,4′-Dithiodiphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(4-hydroxyphenyl)disulfanyl]phenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4′-Dithiodiphenol Use and application,MFCD00020164 technical grade,usp/ep/jp grade.


Related News: ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 4,4′-Disulfanediyldiphenol manufacturer Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. 4,4′-Disulfanediyldiphenol supplier The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 4,4′-Disulfanediyldiphenol vendor United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 4,4′-Disulfanediyldiphenol factory ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib.